Component information
No US or EU label exists for this exact combination, so information is shown for each component.
Use: TIVICAY and TIVICAY PD are indicated in combination with other antiretroviral agents for the treatment of HIV ‑ 1 infection in adults (treatment-naïve or -experienced) and in pediatric patients (treatment-naïve or… US FDA label
Use: EPIVIR is a nucleoside analogue indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV‑1) infection. US FDA label
Use: in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients 2 years of age and older weighing at least 10 kg. US FDA label
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney dosing for each component (single-agent) is shown under Component information.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Film-coated tablet: 50 mg/300 mg/300 mg, 300 mg/300 mg/50 mg
Registered products in the Philippines
7 products registered with the Food and Drug Administration (FDA) Philippines list Dolutegravir + Lamivudine + Tenofovir disoproxil as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products7
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
AcriptegaLamivudine + Tenofovir disoproxil Fumarate + Dolutegravir (as sodium) | 300 mg/300 mg/50 mg Film-Coated TabletBlue colored HDPE Plastic Bottle with blue opaque Polypropylene Cap with silica gel (as dessicant) (Box of 1 bottle x 30 tablets) | Rx | Mylan Laboratories LimitedIndia | Importer: Faberco Life Sciences Inc. | DR-XY48284 | Aug 15, 2027 | |
KovatraxxDolutegravir + Lamivudine + Tenofovir Disoproxil Fumarate | 50 mg/300 mg/ 300 mg Film-Coated Tablet100 cc round white HDPE with continuous thread closure x 30's (box of 30's) 120 cc round white HDPE with continuous thread closure x 30's (box of 30's) 250 cc round white HDPE with continuous thread closure x 90's (box of 90's) 250 cc round white HDPE with continuous thread closure x 100's (box of 100's) 400 ce round white HDPE with continuous thread closure x 180's (box of 180's) | Rx | Macleods Pharmaceuticals LimitedIndia | Macleods Pharmaceuticals Philippines, Inc. | DR-XY49561 | Oct 20, 2030 | |
NoneDolutegravir (as sodium) + Lamivudine + Tenofovir disoproxil fumarate | 50 mg/300 mg/300 mg Film-Coated Tablet100 cc white opaque HDPE bottle (with a 38 mm neck and child-resistant plastic cap with pulp liner) x 30’s (Box of 30’s) | Rx | Hetero Labs LimitedIndia | Camber Pharmaceuticals, Inc. | DR-XY48002 | Aug 11, 2031 | |
TeldyDolutegravir (as sodium) + Lamivudine + Tenofovir disoproxil fumarate | 50 mg/300 mg/300 mg Film Coated TabletWhite opaque HDPE bottle with child-resistant PP cap ottle of 30 tablets in individual box) | Rx | Hetero Labs LimitedIndia | Camber Pharmaceuticals, Inc. | DRP-16612 | Feb 11, 2029 | |
(no brand name)Dolutegravir (as sodium) + Lamivudine + Tenofovir Disoproxil (as fumarate) | 50 mg/300 mg/ 300 mg Film-Coated TabletWhite opaque round HDPE containers closed white opaque polypropylene child resistant closure with induction-sealing wad. | Rx | APL Healthcare Limited, Unit-IVIndia | S.M.H.P. Marketing & Consultancy | DR-XY48976 | Jan 10, 2029 | |
(no brand name)Dolutegravir (as sodium) + Lamivudine + Tenofovir disoproxil fumarate | 50 mg/300 mg/300 mg Film-Coated TabletOpaque white, round HDPE bottle with opaque white, child-resistant PP closure and one (1) silica gel sachet (as desiccant) x 30 tablets (box of 30 tablets) Opaque white, round HDPE bottle with opaque white, child-resistant PP closure and two (2) silica gel sachets (as desiccant) x 90 tablets (box of 90 tablets) Shanghai Desano | Rx | Bio-Pharmaceutical Co., Ltd.China | Biocare Lifesciences, Inc. | DRP-17651 | Feb 12, 2031 | |
(no brand name)Dolutegravir (as sodium) + Lamivudine + Tenofovir Disoproxil Fumarate | 50mg/300mg/300mg Film-Coated TabletHDPE Bottle Pack of 30's with 5g silica (Box of 30 tablets) HDPE Bottle Pack of 90's with 5g silica (Box of 90 tablets) HDPE Bottle Pack of 180's with 5g silica (Box of 180 tablets) | Rx | Sun Pharmaceutical Industries LimitedIndia | Sun Pharma Philippines, Inc. | DR-XY48471 | Nov 17, 2027 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .
